FY2025 EPS Estimates for Revvity Raised by Leerink Partnrs

Revvity, Inc. (NYSE:RVTY - Free Report) - Analysts at Leerink Partnrs boosted their FY2025 earnings per share estimates for shares of Revvity in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $4.93 for the year, up from their prior estimate of $4.90. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q4 2025 earnings at $1.54 EPS, Q2 2026 earnings at $1.43 EPS, Q4 2026 earnings at $1.70 EPS and FY2026 earnings at $5.68 EPS.

A number of other equities analysts also recently weighed in on RVTY. Wells Fargo & Company dropped their target price on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. KeyCorp boosted their target price on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Robert W. Baird cut their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Barclays reduced their price target on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Revvity presently has a consensus rating of "Moderate Buy" and an average price target of $125.64.

Revvity Price Performance

Revvity stock traded down $2.99 during mid-day trading on Thursday, hitting $89.84. The company's stock had a trading volume of 272,484 shares, compared to its average volume of 927,597. The stock's fifty day moving average price is $102.35 and its two-hundred day moving average price is $111.83. The stock has a market capitalization of $10.79 billion, a P/E ratio of 40.49, a P/E/G ratio of 3.82 and a beta of 1.02. Revvity has a twelve month low of $88.53 and a twelve month high of $129.50. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. The firm had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The firm's revenue for the quarter was up 2.3% on a year-over-year basis. During the same period last year, the company earned $0.98 earnings per share.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.31%. The ex-dividend date of this dividend is Friday, July 18th. Revvity's dividend payout ratio is presently 11.91%.

Hedge Funds Weigh In On Revvity

A number of institutional investors have recently added to or reduced their stakes in the business. Tidal Investments LLC grew its position in Revvity by 2,388.8% during the 3rd quarter. Tidal Investments LLC now owns 52,787 shares of the company's stock worth $6,744,000 after acquiring an additional 50,666 shares during the last quarter. Principal Financial Group Inc. lifted its position in Revvity by 3.1% in the 3rd quarter. Principal Financial Group Inc. now owns 141,871 shares of the company's stock valued at $18,124,000 after acquiring an additional 4,263 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Revvity by 13.7% in the third quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock worth $43,961,000 after purchasing an additional 41,497 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Revvity by 10.8% in the fourth quarter. GAMMA Investing LLC now owns 1,898 shares of the company's stock valued at $212,000 after acquiring an additional 185 shares during the period. Finally, Nordea Investment Management AB increased its position in Revvity by 8.0% in the fourth quarter. Nordea Investment Management AB now owns 9,681 shares of the company's stock worth $1,084,000 after buying an additional 719 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.